SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001140361-22-032892
Filing Date
2022-09-09
Accepted
2022-09-09 16:05:28
Documents
14
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A brhc10041759_10ka.htm   iXBRL 10-K/A 42289
2 EXHIBIT 31.1 brhc10041759_ex31-1.htm EX-31.1 10382
3 EXHIBIT 31.2 brhc10041759_ex31-2.htm EX-31.2 12869
  Complete submission text file 0001140361-22-032892.txt   261490

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA kron-20211231.xsd EX-101.SCH 3868
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE kron-20211231_lab.xml EX-101.LAB 28890
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kron-20211231_pre.xml EX-101.PRE 20463
8 EXTRACTED XBRL INSTANCE DOCUMENT brhc10041759_10ka_htm.xml XML 7147
Mailing Address 1300 S. EL CAMINO REAL SUITE 400 SAN MATEO CA 94402
Business Address 1300 S. EL CAMINO REAL SUITE 400 SAN MATEO CA 94402 212-871-7920
Kronos Bio, Inc. (Filer) CIK: 0001741830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39592 | Film No.: 221236087
SIC: 2834 Pharmaceutical Preparations